Page last updated: 2024-11-05

ticlopidine and Muscle Weakness

ticlopidine has been researched along with Muscle Weakness in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SG1
Shim, KS1
Lee, DW1
Kim, EJ1
Lee, SG1
Lee, JH1
An, JH1
Vera, M1
Pou, M1
Botey, A1
Cases, A1

Other Studies

2 other studies available for ticlopidine and Muscle Weakness

ArticleYear
Intramuscular hematoma with motor weakness after trigger point injection: A case report.
    Medicine, 2017, Volume: 96, Issue:39

    Topics: Aged; Biopsy, Fine-Needle; Buttocks; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; F

2017
[Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6

    Topics: Anticholesteremic Agents; Anuria; Clopidogrel; Coronary Artery Bypass; Humans; Hypercholesterolemia;

2001